company-logo

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH1902, which is in Phase 1/Part A clinical trials for the treatment of triple negative breast cancer; and TH1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Theratechnologies Dividend Announcement

Theratechnologies does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Theratechnologies dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Theratechnologies Dividend History

Theratechnologies Dividend Yield

Theratechnologies current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Theratechnologies stock? Use our calculator to estimate your expected dividend yield:

Theratechnologies Financial Ratios

P/E ratio-18.87
PEG ratio7.51
P/B ratio-2.99
ROE14.10%
Payout ratio0.00%
Current ratio1.08
Quick ratio0.97
Cash Ratio0.66

Theratechnologies Dividend FAQ

Does Theratechnologies stock pay dividends?
Theratechnologies does not currently pay dividends to its shareholders.
Has Theratechnologies ever paid a dividend?
No, Theratechnologies has no a history of paying dividends to its shareholders. Theratechnologies is not known for its dividend payments.
Why doesn't Theratechnologies pay dividends?
There are several potential reasons why Theratechnologies would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Theratechnologies ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Theratechnologies has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Theratechnologies a dividend aristocrat?
Theratechnologies is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Theratechnologies a dividend king?
Theratechnologies is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Theratechnologies a dividend stock?
No, Theratechnologies is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Theratechnologies stocks?
To buy Theratechnologies you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Theratechnologies stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.